King Rachel K.
Fulcrum Therapeutics, Inc. · Director
King Rachel K. is listed in public filings as director. This King Rachel K. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Fulcrum Therapeutics, Inc. (FULC), and Novavax, Inc. (NVAX). Investors use King Rachel K.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $266k36k shares | Grant / ExerciseJun 26, 2025 | $265.7K36k shares | $7.38 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --18.9k shares | Grant / ExerciseJun 20, 2025 | Disclosure amount unavailable18.9k shares | -- | -- | |
| $182k28.3k shares | Grant / ExerciseJun 20, 2025 | $181.9K28.3k shares | $6.42 | -- | |
| --10.4k shares | Grant / ExerciseJun 12, 2025 | Disclosure amount unavailable10.4k shares | -- | -- | |
| $133k14.8k shares | SellDec 13, 2024 | $37.4K4.2k shares | $9.02 | -- | |
| $218k60k shares | Grant / ExerciseNov 12, 2024 | $218.4K60k shares | $3.64 | -- | |
| $248k15.6k shares | Grant / ExerciseJun 12, 2024 | $247.9K15.6k shares | $15.86 | -- | |
| --6.7k shares | Grant / ExerciseJun 12, 2024 | Disclosure amount unavailable6.7k shares | -- | -- | |
| --10.4k shares | Grant / ExerciseJun 12, 2024 | Disclosure amount unavailable10.4k shares | -- | -- |